PROVE IT-TIMI 22 compared the efficacy of atorvastatin vs. pravastatin and the clinical efficacy of the antibiotic gatifloxacin vs. placebo in a 2 x 2 factorial design among patients presenting with unstable angina or non-Q-wave myocardial infarction.
MAIN RESULTS:
Intensive versus moderate lipid lowering with statins after acute coronary syndromes

N Engl J Med. 2004 Apr 8;350(15):1495-504.
PRESENTATIONS
OTHER PUBLICATIONS
The next step in cardiovascular protection. Atheroscler Suppl. 2003 Dec;4(5):3-9.
C-reactive protein levels and outcomes after statin therapy. N Engl J Med. 2005 Jan 6;352(1):20-8.
Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):424-30.